• Jordan-founded pharmaceutical e-commerce platform DawaDose has raised a pre-seed funding round from angel investors for an undisclosed value. 
• Founded in 2019 by Rushdi Abdalghani and Osama Almabroum, DawaDose connects pharmacies, wholesalers, and consumers through secure, efficient, and accessible digital tools.
• In coincidence with the round announcement, the company has announced the relocation of its HQ to Saudi Arabia. 
• With this funding, DawaDose will accelerate the development of its Arabic-first AI-driven digital tools, strengthen its partnerships with local pharmacies and distributors, and prepare for regional expansion.

Press release:

DawaDose, the Saudi-headquartered healthtech startup, announced the successful close of its Pre-Seed funding round with participation from a group of angel investors. With this milestone, the company has officially begun setting up its headquarters in Saudi Arabia, positioning the Kingdom as the hub for development, operations, and its expansion across the Saudi and Gulf markets.

Founded by Rushdi Abdalghani (Co-Founder & CEO) and Osama Almabroum (Co-Founder & Business Development Lead), DawaDose is on a mission to digitise access to healthcare by building the region’s first fully integrated B2C and B2B pharmaceutical ecosystem. The platform aims to connect pharmacies, wholesalers, and consumers through secure, efficient, and accessible digital tools, aligned with Saudi Arabia’s Vision 2030.

“This funding is not just capital; it’s trust — trust in our vision to digitise healthcare access across the Middle East, starting with Saudi Arabia,” said Rushdi Abdalghani. “We are building DawaDose as a Saudi company with a global outlook. This is just the first step toward reshaping pharmaceutical e-commerce in the region,” added Osama Almabroum.

With this funding, DawaDose will accelerate the development of its Arabic-first AI-driven digital tools, strengthen its partnerships with local pharmacies and distributors, and prepare for regional expansion.